212 related articles for article (PubMed ID: 14759556)
1. Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.
Gironacci MM; Yujnovsky I; Gorzalczany S; Taira C; Peña C
Regul Pept; 2004 Apr; 118(1-2):45-9. PubMed ID: 14759556
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats.
Gironacci MM; Valera MS; Yujnovsky I; Peña C
Hypertension; 2004 Nov; 44(5):783-7. PubMed ID: 15381673
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-(1-7) reduces norepinephrine release through a nitric oxide mechanism in rat hypothalamus.
Gironacci MM; Vatta M; Rodriguez-Fermepín M; Fernández BE; Peña C
Hypertension; 2000 Jun; 35(6):1248-52. PubMed ID: 10856272
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
Sasaoka T; Egi Y; Tawa M; Yamamoto A; Ohkita M; Takaoka M; Maruyama T; Akira T; Matsumura Y
J Cardiovasc Pharmacol; 2008 Aug; 52(2):176-83. PubMed ID: 18670361
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Fernandes L; Fortes ZB; Nigro D; Tostes RC; Santos RA; Catelli De Carvalho MH
Hypertension; 2001 Feb; 37(2 Pt 2):703-9. PubMed ID: 11230360
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.
Byku M; Macarthur H; Westfall TC
Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H457-65. PubMed ID: 19933420
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria.
Gironacci MM; Adler-Graschinsky E; Peña C; Enero MA
Hypertension; 1994 Oct; 24(4):457-60. PubMed ID: 8088911
[TBL] [Abstract][Full Text] [Related]
9. Evidence for Mas-mediated bradykinin potentiation by the angiotensin-(1-7) nonpeptide mimic AVE 0991 in normotensive rats.
Carvalho MB; Duarte FV; Faria-Silva R; Fauler B; da Mata Machado LT; de Paula RD; Campagnole-Santos MJ; Santos RA
Hypertension; 2007 Oct; 50(4):762-7. PubMed ID: 17664388
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-(1-7) does not affect norepinephrine neuronal uptake or catabolism in rat hypothalamus and atria.
Gironacci MM; Rodríguez-Fermepín M; Vatta M; Fernandez BE; Rubio M; Peña C
Cell Mol Neurobiol; 2000 Dec; 20(6):773-9. PubMed ID: 11100983
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin 1-7 induces bradykinin-mediated relaxation in porcine coronary artery.
Gorelik G; Carbini LA; Scicli AG
J Pharmacol Exp Ther; 1998 Jul; 286(1):403-10. PubMed ID: 9655885
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-(1-7) and other bioactive components of the renin-angiotensin system on vascular resistance and noradrenaline release in rat kidney.
Stegbauer J; Vonend O; Oberhauser V; Rump LC
J Hypertens; 2003 Jul; 21(7):1391-9. PubMed ID: 12817189
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+ -ATPase activity through AT2 receptor.
De Souza AM; Lopes AG; Pizzino CP; Fossari RN; Miguel NC; Cardozo FP; Abi-Abib R; Fernandes MS; Santos DP; Caruso-Neves C
Regul Pept; 2004 Aug; 120(1-3):167-75. PubMed ID: 15177935
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Iyer SN; Ferrario CM; Chappell MC
Hypertension; 1998 Jan; 31(1 Pt 2):356-61. PubMed ID: 9453328
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a functional interaction of the angiotensin-(1-7) receptor Mas with AT1 and AT2 receptors in the mouse heart.
Castro CH; Santos RA; Ferreira AJ; Bader M; Alenina N; Almeida AP
Hypertension; 2005 Oct; 46(4):937-42. PubMed ID: 16157793
[TBL] [Abstract][Full Text] [Related]
16. Biphasic effects of angiotensin (1-7) and its interactions with angiotensin II in rat aorta.
Haulica I; Bild W; Mihaila CN; Ionita T; Boisteanu CP; Neagu B
J Renin Angiotensin Aldosterone Syst; 2003 Jun; 4(2):124-8. PubMed ID: 12806596
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats.
Walters PE; Gaspari TA; Widdop RE
Hypertension; 2005 May; 45(5):960-6. PubMed ID: 15767466
[TBL] [Abstract][Full Text] [Related]
18. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors.
Ognibene DT; Oliveira PR; Marins de Carvalho LC; Costa CA; Espinoza LA; Criddle DN; Tano T; Soares de Moura R; Resende AC
Clin Exp Pharmacol Physiol; 2009 Jan; 36(1):12-9. PubMed ID: 18986337
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats.
Silva DM; Vianna HR; Cortes SF; Campagnole-Santos MJ; Santos RA; Lemos VS
Peptides; 2007 Mar; 28(3):702-7. PubMed ID: 17129638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
